|
COURSE DESCRIPTION
This evidence-based course explores the adverse neurological impact of cancer and its treatment on patients. The rehabilitation management of fall risk, chemotherapy induced peripheral neuropathy (CIPN), and other balance impairments will be addressed. Beginning with an overview of contributing causal pathways, this course will equip clinicians with the most up to date evidence and tools related to the assessment and management of chemotherapy-related balance impairments. Special attention will be given to appropriate outcome selection throughout the continuum of care, subjective interview considerations and goal setting.
WHO SHOULD ATTEND?
The course is of interest to all oncology rehabilitation professionals including massage therapists, physical therapists, occupational therapists, and physical and occupational therapist assistants with all levels of experience, however, the content is most appropriate for intermediate and advanced clinicians. It is also of interest to therapists who are working in an out-patient rehabilitation setting who are interested in enhancing their understanding and skills to better care for patients during and after chemotherapy treatment.
SPEAKERS
Keynote Speaker Stephen Wechsler, PT, DPT, Ph.D. with TurningPoint Oncology Rehabilitation Clinicians.
Stephen Wechsler, PT, DPT, Ph.D.
Board Certified Clinical Specialist in Neurologic Physical Therapy
Post-doctoral Research Fellow, Cancer Rehabilitation (CaRe) Lab
MGH Institute of Health Professions, Boston, MA
COURSE DETAILS
Course Fee*: $325.00 US | $350 After October 1st
Continuing Education Credit: 11.75 contact hours have been applied for through PTAG and GOTA
Questions: For questions or information on group discount, please email us.
*Course fee includes light lunch Friday, break snacks, and access to all course handouts and associated readings.
|
